Reversible neutropenia and thrombocytopenia during famotidine treatment
Ann Pharmacother
.
1994 Mar;28(3):406-7.
doi: 10.1177/106002809402800326.
Authors
O Oymak
,
T Akpolat
,
N Arik
,
U Yasavul
,
C Turgan
,
S Caglar
PMID:
8193440
DOI:
10.1177/106002809402800326
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Famotidine / adverse effects*
Humans
Kidney Failure, Chronic / complications
Male
Middle Aged
Neutropenia / chemically induced*
Thrombocytopenia / chemically induced*
Substances
Famotidine